Phillyrin Prevents Ovariectomy-Induced Osteolysis by Inhibiting Osteoclast Differentiation

Postmenopausal osteoporosis is a metabolic disease caused by an imbalance between osteoclasts and osteoblasts. At present, the drug strategy for treating postmenopausal osteoporosis has some limitations and is unable to satisfy the demands of patients. Phillyrin (Phil) is an herbal extract from Fors...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Geng, Zhang, Ying, Wang, Cong, Zhou, Chenhe, Yan, Shigui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205725/
https://www.ncbi.nlm.nih.gov/pubmed/35722159
http://dx.doi.org/10.1155/2022/6065494

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205725/
https://www.ncbi.nlm.nih.gov/pubmed/35722159
http://dx.doi.org/10.1155/2022/6065494

Ejemplares similares